| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/09/2014 | US8829175 Nucleic acids encoding polyvalent protein complexes |
| 09/09/2014 | US8829166 Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue |
| 09/09/2014 | US8829161 Fusion polypeptide comprising NtHMA transporter |
| 09/09/2014 | US8829158 Peptides, derivatives and analogs thereof, and methods of using same |
| 09/09/2014 | US8829157 Process for the synthesis of cyclic heptapeptide |
| 09/09/2014 | US8828961 Methods and compositions to protect aquatic invertebrates from disease |
| 09/09/2014 | US8828945 Inactivation of smooth muscle tissue |
| 09/09/2014 | US8828941 Composition and method for the treatment or prevention of spinal disorders |
| 09/09/2014 | US8828940 Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands |
| 09/09/2014 | US8828939 Modified vitamin K dependent polypeptides |
| 09/09/2014 | US8828937 Bone morphogenetic protein 2 (BMP2) variants with reduced BMP antagonist sensitivity |
| 09/09/2014 | US8828933 Mutant tat proteins and uses thereof |
| 09/09/2014 | US8828932 Bifunctional molecules for inactivating HIV and blocking HIV entry |
| 09/09/2014 | US8828931 Bifunctional molecules for inhibiting HIV entry |
| 09/09/2014 | US8828929 Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof |
| 09/09/2014 | US8828928 Amphiphilic peptides and peptide particles |
| 09/09/2014 | US8828927 Elastin digest compositions and methods utilizing same |
| 09/09/2014 | US8828926 Uses of natriuretic peptide constructs |
| 09/09/2014 | US8828923 Insulin derivatives |
| 09/09/2014 | US8828922 HSP therapy in conjunction with a low antigenicity diet |
| 09/09/2014 | US8828724 Method for preparing cells for engraftment |
| 09/09/2014 | US8828723 Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC |
| 09/09/2014 | US8828698 Immobilized angiogenin mixtures and uses thereof |
| 09/09/2014 | US8828686 Polynucleotides encoding therapeutic inhibitors of PAI-1 |
| 09/09/2014 | US8828685 Monomeric forms of human aminoacyl-t-RNA synthetases having non-canonical biological activities |
| 09/09/2014 | US8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA |
| 09/09/2014 | US8828665 Compounds and methods for use in detecting gabapentin |
| 09/09/2014 | US8828660 Compositions, reaction mixtures and methods for detecting nucleic acids from multiple types of human papillomavirus |
| 09/09/2014 | US8828408 Compositions and methods for vaccinating against HSV-2 |
| 09/09/2014 | US8828407 Chimaeric protein |
| 09/09/2014 | US8828406 Influenza viruses and uses thereof |
| 09/09/2014 | US8828403 Anti-tumor immunotherapy |
| 09/09/2014 | US8828391 Method for EGFR directed combination treatment of non-small cell lung cancer |
| 09/09/2014 | US8828238 Thermophilic bacterium and uses of extracellular proteins therefrom |
| 09/09/2014 | CA2813431C Production of butanol from carbon monoxide by a recombinant microorganism |
| 09/09/2014 | CA2694805C Immunogenic epitopes of tumour-associated antigens |
| 09/09/2014 | CA2694735C Cell-penetrating peptides and use thereof bonded to biomolecules with therapeutic action |
| 09/09/2014 | CA2693154C Insulinotropic peptide derivative wherein its n-terminal amino acid is modified |
| 09/09/2014 | CA2655933C Polynucleotides and polypeptide sequences involved in cancer |
| 09/09/2014 | CA2638828C Immunomodulatory and anti-tumor peptides derived from lalf |
| 09/09/2014 | CA2634760C Compositions and methods for producing a composition |
| 09/09/2014 | CA2585231C Self-assembling split-fluorescent protein systems |
| 09/09/2014 | CA2576798C Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 09/09/2014 | CA2473733C Cytokine receptor zcytor17 multimers |
| 09/09/2014 | CA2400256C Compositions useful for regulating parkin gene activity |
| 09/09/2014 | CA2395585C Chimeric natriuretic peptides |
| 09/09/2014 | CA2379623C Immunologically significant herpes simplex virus antigens |
| 09/09/2014 | CA2295935C Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 09/09/2014 | CA2284078C A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
| 09/09/2014 | CA2258721C Chimeric heteromultimer adhesins |
| 09/04/2014 | WO2014134619A2 Processes for isolating salicyclic acid receptors |
| 09/04/2014 | WO2014134439A1 Immunogenic composition for mers coronavirus infection |
| 09/04/2014 | WO2014134071A1 Formulations and methods for increased recombinant protein production |
| 09/04/2014 | WO2014131815A1 Peptides for use in the topical treatment of retinal neurodegenerative disesases, in particular in early stages of diabetic retinopathy and other retinal diseases in which neurodegeneration plays an essential role |
| 09/04/2014 | WO2014131714A1 Agents, kits and methods for complement factor h-related protein 1 detection |
| 09/04/2014 | WO2014110163A3 Melk regulation for the treatment of breast cancer |
| 09/04/2014 | WO2014081702A4 Synthetic linear apelin mimetics for the treatment of heart failure |
| 09/04/2014 | WO2014066392A3 Compositions and methods for regulating arterial tone |
| 09/04/2014 | WO2013109342A8 Method of treating diabetes using non-glycosylated apolipoprotein a-iv |
| 09/04/2014 | WO2013082519A3 Nucleotide-specific recognition sequences for designer tal effectors |
| 09/04/2014 | US20140250550 Compositions and methods for modulating anthocyanin accumulation and pistil development |
| 09/04/2014 | US20140249302 Methods for making and using molecular switches involving circular permutation |
| 09/04/2014 | US20140249299 Hybrid polypeptides with selectable properties |
| 09/04/2014 | US20140249295 Light-inducible system for regulating protein stability |
| 09/04/2014 | US20140249094 Sensation-improving agent |
| 09/04/2014 | US20140249089 Methods of treating disease with random copolymers |
| 09/04/2014 | US20140249086 Method for Improving the Stability of Purified Factor VIII After Reconstitution |
| 09/04/2014 | US20140249082 Pharmaceutical Preparation Comprising Recombinant HcG |
| 09/04/2014 | US20140249078 Whey protein micelles against muscle atrophy and sarcopenia |
| 09/04/2014 | US20140249072 Complement factor b analogs and their uses |
| 09/04/2014 | US20140249052 Polypeptides and their use |
| 09/04/2014 | US20140248695 Viral Vectors Purification System |
| 09/04/2014 | US20140248689 Glucose-induced inactivation/degradation-resistant transporter gene and use thereof |
| 09/04/2014 | US20140248685 Alpha-amylase Mutants |
| 09/04/2014 | US20140248682 Hsa-related compositions and methods of use |
| 09/04/2014 | US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 09/04/2014 | US20140248660 Heterologous intron within a signal peptide |
| 09/04/2014 | US20140248657 Method for producing insoluble aggregate of neurodegenerative-disease-related protein |
| 09/04/2014 | US20140248641 Cloned glucagon-like peptide-2 receptors |
| 09/04/2014 | US20140248603 Quantification of vaccine compositions |
| 09/04/2014 | US20140248314 Pre-fusion rsv f antigens |
| 09/04/2014 | US20140248311 N-terminal deleted gp120 immunogens |
| 09/04/2014 | US20140248309 Dna promoters and anthrax vaccines |
| 09/04/2014 | US20140248306 Lentiviral gene transfer vectors and their medicinal applications |
| 09/04/2014 | US20140248303 Synthetic streptococcus pneumoniae vaccine |
| 09/04/2014 | US20140248302 Recombinant proteins and their therapeutic uses |
| 09/04/2014 | US20140248290 Inhibition of cancer metastasis |
| 09/04/2014 | US20140248272 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 09/04/2014 | US20140248271 Novel human genes relating to respiratory diseases and obesity |
| 09/04/2014 | US20140248260 Use of toll-like receptor agonist for treating cancer |
| 09/04/2014 | US20140248238 Polypeptide constructs and uses thereof |
| 09/04/2014 | US20140246036 Transcription factors that regulate nicotine biosynthesis in tobacco |
| 09/04/2014 | US20140245923 Polypeptide solution, artificial polypeptide fiber production method and polypeptide purification method using same |
| 09/03/2014 | EP2772500A1 Site-directed modification of FVIII |
| 09/03/2014 | EP2772499A1 Separation of plasma proteins |
| 09/03/2014 | EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof |
| 09/03/2014 | EP2772259A1 Method for isolating small molecules with important biological activity using yeast |
| 09/03/2014 | EP2771366A1 Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes |
| 09/03/2014 | EP2771357A1 Genetically modified t cell receptor mice |
| 09/03/2014 | EP2771356A1 Chimeric molecule involving oligomerized fasl extracellular domain |